Table 2.
Oral–gut microbiome axis in liver diseases.
Disease | Association with Oral and Gut Microbiomes | References |
---|---|---|
Chronic liver diseases | Association with gut microbiome | |
• Gut dysbiosis in NAFLD | [149,150] | |
• Gut dysbiosis in NASH | [151,152,153] | |
• Gut dysbiosis in cirrhosis | [152] | |
Gut–liver microbiome axis | ||
• Gut-to-liver translocation by biliary obstruction | [158,159] | |
• Concomitant shifts in the biliary tract and gut microbiomes in gallstone patients | [160] | |
Association with oral microbiome | ||
• Concomitant shifts in the oral and gut microbiomes in cirrhosis | [163] | |
• Periodontitis was associated with NASH, NAFLD, and cirrhosis | [164,165,166,167] | |
• Oral administration of P. gingivalis accelerated progression of NAFLD and NASH in high fat diet-fed mice | [170,171] | |
Prevalence of oral microbiota | ||
• Colonization of oral bacteria in the gut of cirrhosis patients | [152] | |
HCC | Association with gut microbiome | |
• Gut dysbiosis in HCC patients | [175] | |
• Prevalence of E. coli and Fusobacteria in the gut microbiome of HCC patients with cirrhosis | [177,178] | |
Association with oral microbiome | ||
• Altered oral microbiome in HCC patients | [183,184,185] | |
• Prevalence of Fusobacterium and Oribacterium in the tongue microbiome of HCC patients with cirrhosis | [185] | |
• Periodontitis was associate with advanced HCC stages | [186] | |
Prevalence of oral microbiota | ||
• Prevalence of Fusobacterium in both oral and gut microbiomes of HCC patients with cirrhosis | [176,178,185] |